Skip to content

BD® Quincke Spinal Needle 405161Recalls & reported problems

Becton, Dickinson And Company · NEEDLE SPINAL S/SU 22GA 1-1/2IN QUINCKE · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00382904051617), received between May 23, 2024 and Jan 11, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Complete Blockage” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Complete Blockage1
  • Defective Component1

Patient problems

  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 11, 2025Complete Blockage; Complete Blockage

    MATERIAL # 405161. BATCH # UNKNOWN. VERBATIM: "IN THE PAST WE COULD USE ONE NEEDLE AND SWITCH THE SYRINGE OUT WITH THE THREE INJECTIONS: LIDOCAINE, OMNIPAQUE 300, AND THE STEROID. IT IS BEING REPORTED THAT THEY ARE HAVING ISSUES WITH THE NEEDLE AFTER THE OMNIPAQUE IS INJECTED." CUSTOMER RESPONSE RECEIVED ON (B)(6)2025. 1. COULD YOU PLEASE PROVIDE A FURTHER DESCRIPTION OF THE ISSUE? WHAT KIND OF ISSUE THEY WERE FACED? DIFFICULTY ADMINISTERING STEROID THROUGH 25G BD 1.5¿ NEEDLES FOR STEROID JOINT INJECTIONS. I HAVE BEEN USING THESE NEEDLES FOR GREATER THAN ONE YEAR FOR JOINT INJECTIONS. RECENTLY IN THE LAST MONTH, I WILL GET THE NEEDLE IN PLACE, INJECT OMNIPAQUE 300 THROUGH THE NEEDLE TO CONFIRM CORRECT NEEDLE PLACEMENT AND THEN GO TO INJECT THE STEROID AND WILL BE UNABLE TO PUSH ANYTHING THROUGH THE NEEDLE. I HAVE BEEN DOING THE SAME TECHNIQUE WITH THE SAME EQUIPMENT AND THE SAME MEDICATIONS FOR GREATER THAN ONE YEAR. IT WAS JUST OVER THE PAST MONTH OR SO THAT THIS PROBLEM HAS ARISEN. 2. CAN YOU PLEASE PROVIDE AN EXACT DATE OF EVENT IN THIS FORMAT MM-DD-YYYY? APPROXIMATELY FROM THE END OF (B)(6) 2024 TO PRESENT DAY. 3. PLEASE SHARE THE LOT NUMBER ASSOCIATED WITH REPORTED ISSUE 32095

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21133537 ↗
  • MalfunctionMay 23, 2024Defective Component; Defective Component

    NO ADDITIONAL INFORMATION.

    Patient problems: Insufficient Information

    MAUDE report 19380516 ↗

Other NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices

All NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.